The global tumor ablation market attained a value of USD 1.90 Billion in 2024. The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 14.20%, to reach USD 7.17 Billion by 2034.
Base Year
Historical Period
Forecast Period
According to the American Cancer Society Statistics, it is estimated that 2,001,140 new cases and 611,720 cancer mortality are projected to occur in the United States in 2024.
In March 2024, Medtronic received United States FDA 510(k) approval for OsteoCool 2.0, an ablation system designed to treat benign bone tumors.
Growing preference for minimally invasive procedures is expected to fuel the tumor ablation market value in the forecast period.
Compound Annual Growth Rate
14.2%
Value in USD Billion
2025-2034
Tumor Ablation Market Outlook
*this image is indicative*
Tumour ablation is a minimally invasive procedure commonly employed to treat tumors of the kidney, liver, bone, and lung. It is a promising alternative for patients with failed radiotherapy or chemotherapy. This technique generally uses thermal energy to heat or cool the targeted tissue to cytotoxic levels, resulting in tissue necrosis. The technical success and minimally invasive nature have fuelled its clinical relevance which is expected to drive market growth in coming years.
Major factors propelling the market expansion are the growing incidence and prevalence of cancers, continuous technological innovation in the field of tumor ablation, and the surge in research and development activities. The market landscape is likely to be positively influenced by the rising investment from the public and private sectors to foster the development of tumor ablation procedures along with the heightened public awareness related to the benefits of the technique. Moreover, the tumor ablation market demand is fuelled by the rising inclination of patients towards minimally invasive alternatives for cancer treatment.
Growing adoption of image-guided ablation, expanding applications of tumor ablation, heightened patient awareness, and the surge in regulatory approvals comprise some of the key trends and developments in the market.
Medtronic plcThe company received the United States Food and Drug Administration (FDA) 510(k) approval for OsteoCool 2.0, a bone tumor ablation system to treat benign bone tumors and painful bone metastases.
Techsomed’s ablation treatment planning software VisAble.IO was granted 510(k) clearance by the FDA. The software integrated with artificial intelligence (AI) offers a three-dimensional (3D) view of the ablation target, marking an innovation in image-guided ablation therapy.
Brain Navi demonstrated its NaoTrac neurosurgical navigation robot and KrystoLens single-use neuro-endoscope at several conferences. NaoTrac facilitated non-invasive patient registration in two minutes while supporting neurological procedures such as tumour ablation and biopsy.
Baird Medical, a Chinese corporation specializing in microwave ablation medical devices, signed a definitive agreement to merge with ExcelFin Acquisition, forming Baird Medical Investment Holdings upon deal completion. With a minimum of USD 15 million closing cash condition, the merged company is projected to hold a value of USD 370 million.
The market is driven by the rising prevalence and incidence of cancer which necessitates the development of effective treatment interventions for the huge patient base. The global burden of cancer is primarily contributed by the rise in the geriatric population and increased exposure to risk factors. With estimates predicting more than 35 million new cancer cases by 2050 , the tumor ablation market value is expected to witness significant growth in the forecast period.
One of the major market trends is the rapid technological advancement in the field of tumor ablation, encouraged by investments from the key market players. Moreover, the robust financial support from the government is helping to sustain the ongoing research initiatives aimed at improving patient outcomes via innovative tumor ablation procedures. Moreover, the inclination of patients for less invasive treatment options is a significant trend accelerating market growth.
“Global Tumor Ablation Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Breakup by Technology
Breakup by Type
Breakup by Application
Breakup by End User
Breakup by Region
The key market players are contributing to the tumor ablation market growth through mergers and acquisitions initiatives, innovative product launches, continuous research, and development efforts, and penetration of their offerings in the international markets.
| Company | Year Founded | Headquarters | Products/Services |
| Medtronic PLC | 1949 | Dublin, Ireland | Offers a range of ablation products, including radiofrequency ablation systems and thermosphere ablation systems. |
| Boston Scientific Corporation | 1979 | Marlborough, Massachusetts, USA | Provides various ablation solutions, including cryoablation and radiofrequency ablation (RFA). |
| Johnson & Johnson | 1886 | New Brunswick, New Jersey, USA | Through its subsidiary, Ethicon offers microwave ablation technology among other medical devices and pharmaceuticals. |
| AngioDynamics | 1988 | Latham, New York, USA | Specializes in image-guided, minimally invasive therapies, including NanoKnife for irreversible electroporation, and offers microwave and radiofrequency ablation products. |
Other key market players include EDP TMS, Mermaid Medical, CONMED Corporation, Sonablate Corporation, Integra Life Science Holding Corporation, Smith & Nephew PLC, and Olympus Corporation, among others.
North America has a significant share of the market segment, which can be attributed to the growing cancer burden in the region and the growing demand for novel treatment interventions. In addition, increasing geriatric population, product launches, and vigorous research and development initiatives are expected to bolster the market growth in the forecast period.
Europe has a substantial market value, supported by the presence of premium research institutes and key market leaders. Moreover, the advanced healthcare system in the region facilitates greater accessibility to innovative tumor ablation techniques, which is likely to drive market growth in the region.
Tumor Ablation Market Analysis
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 1.90 Billion in 2024 driven by the rising prevalence and incidence of cancer across the globe.
The market is anticipated to grow at a CAGR of USD 7.17 Billion% during the forecast period of 2025-2034, likely to reach a market value of USD 7.17 Billion by 2034.
The inclination of patients towards less invasive treatment options is fuelling the demand for the market.
One of the significant trends in the market is the surge in approvals from regulatory bodies. In March 2024, Medtronic plc received the United States FDA 510(k) approval for OsteoCool 2.0 (a bone tumor ablation system) to treat benign bone tumors and painful bone metastases.
Based on the technology, the market is segmented into radiofrequency ablation, microwave ablation, cryoablation, HIFU, and others.
Based on the type, the market is segmented into surgical ablation, percutaneous ablation, and laparoscopic ablation.
Major end users of tumor ablation include hospitals, oncology centers, and others.
Common application areas include kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and bone cancer.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson, EDP TMS, Mermaid Medical, CONMED Corporation, Sonablate Corporation, Integra Life Science Holding Corporation, Olympus Corporation, and Smith & Nephew PLC, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
